益普生宣布其(qi)藥品達菲林六月劑(ji)型(xing)在(zai)中(zhong)國(guo)獲批,用于(yu)治療中(zhong)樞性(xing)(xing)性(xing)(xing)早熟(CPP),成(cheng)為國(guo)內首個此(ci)類超長效劑(ji)型(xing)。該藥物通(tong)過減少給藥次數,提高依從(cong)性(xing)(xing)和患兒(er)舒適(shi)度。(美通(tong)社)